Correlated flow cytometric analysis of H-ras p21 and DNA ploidy in acute myelogenous leukemia

Abstract

The flow cytometric immunoassay was used to study the correlation between the H-ras oncogene product p21 and the DNA ploidy in 30de novo cases of acute myelogenous leukemia (AML). The results showed that 17 cases were negative for p21 expression and 13 positive for p21. The patients with positive p21 had higher percentage of bone marrow and peripheral blasts and lower peripheral leukocyte count. The expression of p21 had no influence on the therapeutic effect. Before treatment, DNA diploidy occurred in 18 cases including 13 p21 negative ones, and DNA aneuploidy was revealed in 12 cases including 8 p21 positive ones. Patients with positive p21 or having, aneuploidy in complete remission were at risk for early relapse. Our results suggest that p21 may be involved in the process of leukemogenesis and progression in AML.

Keywords

ras oncogene product p21 / DNA ploidy / flow cytometry / acute myelogenous / leukemia

References

[1] BosJ L. Ras oncogene in human cancer: A review. Cancer Res, 1989, 49: 4-682

[2] ZhangR X, YaoE G. The prognostic significance of flow cytometric DNA measurement in acute leukemia. Chin J Hematol, 1989, 10: 415-415

[3] ZhangR X, YaoE G. Flow cytometric DNA measurement for prediction of effect of therapy in acute leukemia. J Tongji Med Uni, 1990, 10: 415-415

[4] ZhangR X, YaoE G. Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia. Chin Med J, 1990, 103: 826-826

[5] QiF Y, QinT W, LiuXY, et al.. Study on the expression of ras oncogene product p21 and DNA ploidy in oral squamous cell carcinoma. J Chin Phy Med, 1993, 15: 24-24

[6] LinF R, YaoE G, XuS R, et al.. Functional status of pancreatic islet in acute leukemia. Chin Med J, 1994, 107: 827-827

[7] GiordanoM, DanovaM, RiccardiA, et al.. Simultaneous detection of cellular ras oncogene product and DNA content by two parameter flow cytometry. Anticancer Res, 1989, 9: 799-799

[8] AndreeffM, SlaterD E, BreesslerJ, et al.. Cellular ras oncogene expression and cell cycle measured by flow cytometry in hematopoietic cell lines. Blood, 1986, 67: 676-676

[9] DongW R, GaoP U, WanY, et al.. Immunocytochemical study on ras oncogene product p21 in leukemia cells. J Chin Med Uni, 1992, 21: 202-202